<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	>

<channel>
	<title>PR Hub &#187; Teva Uk Ltd</title>
	<atom:link href="http://pr.gaeatimes.com/t/teva-uk-ltd/feed/" rel="self" type="application/rss+xml" />
	<link>http://pr.gaeatimes.com</link>
	<description></description>
	<pubDate>Fri, 09 Dec 2011 05:00:00 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.7.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Teva UK Limited Launches Generic Anti-obesity Drug Orlistat</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-anti-obesity-drug-orlistat-54591/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-anti-obesity-drug-orlistat-54591/#comments</comments>
		<pubDate>Fri, 09 Dec 2011 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[December 9]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teva-uk-limited-launches-generic-anti-obesity-drug-orlistat-54591/</guid>
		<description><![CDATA[CASTLEFORD, England, December 9, 2011  -

We are delighted to announce the first generic launch of Orlistat, generic equivalent to Xenical® (Orlistat) from Roche.  
Orlistat from Teva UK Limited is available immediately as:

    Product         Strength        Pack size .... Read the original article &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-generic-anti-obesity-drug-orlistat-54591/">here</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-anti-obesity-drug-orlistat-54591/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Generic Valsartan and Valsartan HCTZ</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-valsartan-and-valsartan-hctz-53367/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-valsartan-and-valsartan-hctz-53367/#comments</comments>
		<pubDate>Tue, 15 Nov 2011 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[November 15]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teva-uk-limited-launches-generic-valsartan-and-valsartan-hctz-53367/</guid>
		<description><![CDATA[CASTLEFORD, England, November 15, 2011  -

We are pleased to announce the day-one launch of generic Valsartan tablets and capsules, and Valsartan Hydrochlorothiazide (HCTZ) tablets.
Valsartan is a generic version of Diovan® (Valsartan) and Valsartan HCTZ is the generic version Co-Diovan® (Valsartan HCTZ); both from Novartis.  They are indicated in the treatments of Heart failure, Hypertension .... Source article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-generic-valsartan-and-valsartan-hctz-53367/">Teva UK Limited Launches Generic Valsartan and Valsartan HCTZ</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-valsartan-and-valsartan-hctz-53367/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Generic Salmeterol (Salmeterol xinafoate) pMDI</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-salmeterol-salmeterol-xinafoate-pmdi-51532/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-salmeterol-salmeterol-xinafoate-pmdi-51532/#comments</comments>
		<pubDate>Fri, 07 Oct 2011 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[October 7]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teva-uk-limited-launches-generic-salmeterol-salmeterol-xinafoate-pmdi-51532/</guid>
		<description><![CDATA[CASTLEFORD, England, October 7, 2011  -

We are pleased to announce the first-to-market launch of generic Salmeterol pMDI.
Salmeterol pMDI is a CFC-free inhaler indicated to help prevent:

Breathing problems caused by asthma including asthma brought on by exercise and asthma at night in adults and adolescents over 12 years of age; and
Breathing problems caused by other .... <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-generic-salmeterol-salmeterol-xinafoate-pmdi-51532/">Source article on Gaea Times at  &nbsp;: Teva UK Limited Launches Generic Salmeterol (Salmeterol xinafoate) pMDI</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-salmeterol-salmeterol-xinafoate-pmdi-51532/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Generic Levetiracetam Tablets</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-levetiracetam-tablets-49996/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-levetiracetam-tablets-49996/#comments</comments>
		<pubDate>Wed, 07 Sep 2011 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 7]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teva-uk-limited-launches-generic-levetiracetam-tablets-49996/</guid>
		<description><![CDATA[CASTLEFORD, England, September 7, 2011  -

We are pleased to announce the launch of generic levetiracetam film-coated tablets.
Levetiracetam is a generic version of Keppra® (levetiracetam) from UCB Pharma Limited and is indicated as a monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with ... Read more <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-generic-levetiracetam-tablets-49996/" title="Teva UK Limited Launches Generic Levetiracetam Tablets">&raquo;&raquo;&raquo;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-levetiracetam-tablets-49996/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva Launches Prednisolone EC Tablets</title>
		<link>http://pr.gaeatimes.com/teva-launches-prednisolone-ec-tablets-38364/</link>
		<comments>http://pr.gaeatimes.com/teva-launches-prednisolone-ec-tablets-38364/#comments</comments>
		<pubDate>Tue, 23 Nov 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[November 23]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teva-launches-prednisolone-ec-tablets-38364/</guid>
		<description><![CDATA[CASTLEFORD, England, November 23, 2010  - We are pleased to announce the launch of a generic version of
Prednisolone enteric-coated (EC) tablets.

    Prednisolone EC tablets are a generic version of Deltacortril(R) from
Alliance Pharmaceuticals Limited and are indicated in the treatment of
inflammatory and allergic conditions such as asthma, rheumatoid arthritis and
colitis.
   ... <a href="http://pr.gaeatimes.com/teva-launches-prednisolone-ec-tablets-38364/">Read the original article on Gaea Times at  : Teva Launches Prednisolone EC Tablets</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-launches-prednisolone-ec-tablets-38364/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-enters-wounds-sector-with-polyhealtm-launch-37964/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-enters-wounds-sector-with-polyhealtm-launch-37964/#comments</comments>
		<pubDate>Mon, 15 Nov 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[November 15]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://pr.gaeatimes.com/teva-uk-limited-enters-wounds-sector-with-polyhealtm-launch-37964/</guid>
		<description><![CDATA[CASTLEFORD, England, November 15, 2010  - Teva UK Limited, a leading supplier of medicines to the NHS, has today
entered the Wound Care sector with the launch of PolyHeal (TM) at the Wounds
UK conference. PolyHeal is a product for hard-to-heal wounds and has been
clinically shown to result in a significant reduction in wound size after
just ... <a href="http://pr.gaeatimes.com/teva-uk-limited-enters-wounds-sector-with-polyhealtm-launch-37964/">Original article on  : Teva UK Limited Enters Wounds Sector With PolyHeal(TM) Launch</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-enters-wounds-sector-with-polyhealtm-launch-37964/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Comments on Department of Health Generic Substitution Outcome</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-comments-on-department-of-health-generic-substitution-outcome-36664/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-comments-on-department-of-health-generic-substitution-outcome-36664/#comments</comments>
		<pubDate>Fri, 15 Oct 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[European Government]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[October 15]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-comments-on-department-of-health-generic-substitution-outcome-36664/</guid>
		<description><![CDATA[CASTLEFORD, England, October 15, 2010  - Teva UK Limited, the UK&#39;s leading manufacturer of generic medicines, has
today commented on the Department of Health&#39;s (DH) decision not to implement
generic substitution in primary care.

    Although deciding not to go ahead with generic substitution as the
original proposals stood, DH has indicated that it will .... <a href="http://pr.gaeatimes.com/teva-uk-limited-comments-on-department-of-health-generic-substitution-outcome-36664/">Source article &nbsp;: Teva UK Limited Comments on Department of Health Generic Substitution Outcome</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-comments-on-department-of-health-generic-substitution-outcome-36664/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Dorzolamide/Timolol Ophthalmic Solution</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamidetimolol-ophthalmic-solution-35901/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamidetimolol-ophthalmic-solution-35901/#comments</comments>
		<pubDate>Mon, 04 Oct 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[October 4]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-launches-dorzolamidetimolol-ophthalmic-solution-35901/</guid>
		<description><![CDATA[CASTLEFORD, England, October 4, 2010  - We are pleased to announce the launch of Dorzolamide/Timolol 20mg/5mg per
ml ophthalmic solution.

    It is indicated in the treatment of elevated intra-ocular pressure (IOP)
in patients with open-angle glaucoma or pseudo-exfoliative glaucoma when
topical beta-blocker monotherapy is not sufficient(1).
    It is a generic version .... Source article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamidetimolol-ophthalmic-solution-35901/">Teva UK Limited Launches Dorzolamide/Timolol Ophthalmic Solution</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamidetimolol-ophthalmic-solution-35901/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Delivers &#34;Good Health for Less.&#34;</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-delivers-good-health-for-less-34064/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-delivers-good-health-for-less-34064/#comments</comments>
		<pubDate>Thu, 02 Sep 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[September 2]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-delivers-good-health-for-less-34064/</guid>
		<description><![CDATA[CASTLEFORD, England, September 2, 2010  - Teva UK Limited, the UK&#39;s leading generics manufacturer, is entering a
whole new market sector by launching an over the counter (OTC) range of
medicines.

    Delivering &#34;Good Health for less&#34;, the comprehensive range will initially
feature high quality analgesic, gastro-intestinal, allergy and cold and flu
relief products, with more .... <a href="http://pr.gaeatimes.com/teva-uk-limited-delivers-good-health-for-less-34064/">Original article on Gaea Times at  &nbsp;: Teva UK Limited Delivers &quot;Good Health for Less.&quot;</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-delivers-good-health-for-less-34064/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Repeats Student Bursary Offer</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-repeats-student-bursary-offer-24756/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-repeats-student-bursary-offer-24756/#comments</comments>
		<pubDate>Mon, 26 Jul 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Awards]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Children Related]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Higher Education]]></category>

		<category><![CDATA[Medical Equipment]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[July 26]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-repeats-student-bursary-offer-24756/</guid>
		<description><![CDATA[CASTLEFORD, England, July 26, 2010  - Teva UK Limited, the UK&#39;s leading generics manufacturer, has opened up
its Student Bursary Scheme for the third year running.

    The company launched the bursary scheme in 2008 as part of plans to
extend its support of pharmacy in the UK. Student bursaries are available to
students who .... Source article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-repeats-student-bursary-offer-24756/">Teva UK Limited Repeats Student Bursary Offer</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-repeats-student-bursary-offer-24756/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Welcomes DH Consultation on COPD Strategy</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-consultation-on-copd-strategy-16211/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-consultation-on-copd-strategy-16211/#comments</comments>
		<pubDate>Mon, 19 Apr 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Surveys / Polls / Research]]></category>

		<category><![CDATA[April 19]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-welcomes-dh-consultation-on-copd-strategy-16211/</guid>
		<description><![CDATA[CASTLEFORD, England, April 19, 2010  - Teva UK Limited has welcomed the Department of Health&#39;s (DH) consultation
on a Strategy for Services for Chronic Obstructive Pulmonary Disease (COPD).

    As well as outlining a strategy for COPD services, the document also
incorporates a strategy for asthma management.
    Says Robyn Hughes, Director .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-consultation-on-copd-strategy-16211/">Teva UK Limited Welcomes DH Consultation on COPD Strategy</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-consultation-on-copd-strategy-16211/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Temozolomide Capsules</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-temozolomide-capsules-15484/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-temozolomide-capsules-15484/#comments</comments>
		<pubDate>Wed, 31 Mar 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[March 31]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-launches-temozolomide-capsules-15484/</guid>
		<description><![CDATA[CASTLEFORD, England, March 31, 2010  - We are pleased to announce the launch of temozolomide available in 5mg,
20mg, 100mg, 140mg, 180mg and 250mg strength capsules. Temozolomide is
indicated for the oncological treatment of brain tumours, specifically(1):


    - adult patients with newly-diagnosed glioblastoma multiforme
      concomitantly with radiotherapy (RT) .... Original source &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-temozolomide-capsules-15484/">Teva UK Limited Launches Temozolomide Capsules</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-temozolomide-capsules-15484/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Generic Losartan</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-losartan-13934/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-losartan-13934/#comments</comments>
		<pubDate>Mon, 01 Mar 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[March 2]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-launches-generic-losartan-13934/</guid>
		<description><![CDATA[CASTLEFORD, England, March 2, 2010  - We are pleased to announce the launch of losartan potassium film-coated
tablets available in 25mg, 50mg and 100mg strengths, in packs of 28. Losartan
is indicated for the treatment of essential hypertension(1).

    It is a generic version of Cozaar(R) Black Triangle Drug (losartan)
from MSD and is available ... <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-generic-losartan-13934/">Original source on Gaea Times at  : Teva UK Limited Launches Generic Losartan</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-generic-losartan-13934/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-lercanidipine-hydrochloride-film-coated-tablets-12391/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-lercanidipine-hydrochloride-film-coated-tablets-12391/#comments</comments>
		<pubDate>Fri, 29 Jan 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-launches-lercanidipine-hydrochloride-film-coated-tablets-12391/</guid>
		<description><![CDATA[CASTLEFORD, England, January 29  - We are pleased to announce the patent expiry launch of lercanidipine
hydrochloride film-coated tablets, available in 10mg and 20mg strengths in
packs of 28. Lercanidipine hydrochloride film-coated tablets are indicated
for the treatment of mild to moderate, essential hypertension(1).

    It is a generic version of Zanidip(R) from Recordati and .... <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-lercanidipine-hydrochloride-film-coated-tablets-12391/">Original article &nbsp;: Teva UK Limited Launches Lercanidipine Hydrochloride Film-Coated Tablets</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-lercanidipine-hydrochloride-film-coated-tablets-12391/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Launches Dorzolamide 2% Eye Drops Solution</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamide-2-eye-drops-solution-12344/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamide-2-eye-drops-solution-12344/#comments</comments>
		<pubDate>Thu, 28 Jan 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-launches-dorzolamide-2-eye-drops-solution-12344/</guid>
		<description><![CDATA[CASTLEFORD, England, January 28  - We are pleased to announce the launch of dorzolamide 2% eye drops
solution available in a 5ml bottle. Dorzolamide solution is indicated as
adjunctive therapy to beta-blockers, as monotherapy in patients unresponsive
to beta-blockers or in whom beta-blockers are contraindicated. Dorzolamide
solution is also used in the treatment of elevated intra-ocular pressure in
ocular ... <a href="http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamide-2-eye-drops-solution-12344/">Read the original article on Gaea Times at  : Teva UK Limited Launches Dorzolamide 2% Eye Drops Solution</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-launches-dorzolamide-2-eye-drops-solution-12344/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva UK Limited Welcomes DH Generic Substitution Consultation</title>
		<link>http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-generic-substitution-consultation-11223/</link>
		<comments>http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-generic-substitution-consultation-11223/#comments</comments>
		<pubDate>Tue, 05 Jan 2010 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[European Government]]></category>

		<category><![CDATA[Government and Policy]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-uk-limited-welcomes-dh-generic-substitution-consultation-11223/</guid>
		<description><![CDATA[CASTLEFORD, England, January 5  - Teva UK Limited has today welcomed the Department of Health&#39;s (DH)
preferred proposal on generic substitution, which follows the announcement of
a three-month consultation.

    The proposal favoured by DH would allow dispensers to switch a
prescription from a named branded medicine to a cheaper generic equivalent
for a selected list .... Original article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-generic-substitution-consultation-11223/">Teva UK Limited Welcomes DH Generic Substitution Consultation</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-uk-limited-welcomes-dh-generic-substitution-consultation-11223/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva Launches Co-Beneldopa (Levodopa/Benserazide)</title>
		<link>http://pr.gaeatimes.com/teva-launches-co-beneldopa-levodopabenserazide-10938/</link>
		<comments>http://pr.gaeatimes.com/teva-launches-co-beneldopa-levodopabenserazide-10938/#comments</comments>
		<pubDate>Fri, 18 Dec 2009 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[Multicultural]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[Senior Citizens]]></category>

		<category><![CDATA[Castleford]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-launches-co-beneldopa-levodopabenserazide-10938/</guid>
		<description><![CDATA[CASTLEFORD, England, December 18  - Teva UK Limited has launched generic co-beneldopa capsules in a variety
of strengths. The company says that they are the first generic to reach the
market.

    &#34;We&#39;re delighted to be launching co-beneldopa capsules,&#34; said Kim Innes,
Commercial Director, Teva UK Limited. &#34;This product fits well with our range
and strengthens ... Read : <a href="http://pr.gaeatimes.com/teva-launches-co-beneldopa-levodopabenserazide-10938/">Teva Launches Co-Beneldopa (Levodopa/Benserazide)</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-launches-co-beneldopa-levodopabenserazide-10938/feed/</wfw:commentRss>
		</item>
		<item>
		<title>Teva Launches TevaGrastim(R) (filgrastim)</title>
		<link>http://pr.gaeatimes.com/teva-launches-tevagrastimr-filgrastim-9153/</link>
		<comments>http://pr.gaeatimes.com/teva-launches-tevagrastimr-filgrastim-9153/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Leeds]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/teva-launches-tevagrastimr-filgrastim-9153/</guid>
		<description><![CDATA[LEEDS, England, November 18  - Teva UK Limited has signalled its commitment to developing biosimilar
medicines by entering the G-CSF* therapy area. The launch of its proprietary
version of filgrastim, TevaGrastim(R), marks the Company&#39;s first biosimilar*,
and represents a major addition to Teva&#39;s Hospitals portfolio.

    TevaGrastim(R) is licensed for a number of indications1, the .... Source article on Gaea Times at  &nbsp;: <a href="http://pr.gaeatimes.com/teva-launches-tevagrastimr-filgrastim-9153/">Teva Launches TevaGrastim(R) (filgrastim)</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/teva-launches-tevagrastimr-filgrastim-9153/feed/</wfw:commentRss>
		</item>
		<item>
		<title>/C O R R E C T I O N &#8212; Teva UK Ltd/</title>
		<link>http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-teva-uk-ltd-9221/</link>
		<comments>http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-teva-uk-ltd-9221/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Teva Uk Ltd</dc:creator>
		
		<category><![CDATA[Biotechnology]]></category>

		<category><![CDATA[Business]]></category>

		<category><![CDATA[Clinical Trials / Medical Discoveries]]></category>

		<category><![CDATA[Health]]></category>

		<category><![CDATA[Health Care / Hospitals]]></category>

		<category><![CDATA[New Products / Services]]></category>

		<category><![CDATA[Pharmaceuticals]]></category>

		<category><![CDATA[England]]></category>

		<category><![CDATA[Leeds]]></category>

		<category><![CDATA[Teva Uk Ltd]]></category>

		<category><![CDATA[United Kingdom]]></category>

		<guid isPermaLink="false">http://blog.taragana.com/pr/c-o-r-r-e-c-t-i-o-n-teva-uk-ltd-9221/</guid>
		<description><![CDATA[LEEDS, England, November 18  - In the news release, &#34;Teva Launches TevaGrastim(R) (filgrastim)&#34; issued on
18 Nov 2009 07:00 GMT, by Teva UK Ltd  over PR Newswire, due to an omission
made by PR Newswire, we did not specify that this is a black triangle drug.
The headline should have read  &#34;Teva
Launches TevaGrastim(R) (Black Triangle ... <a href="http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-teva-uk-ltd-9221/">Read the original article on Gaea Times at  : /C O R R E C T I O N &#8212; Teva UK Ltd/</a>.]]></description>
		<wfw:commentRss>http://pr.gaeatimes.com/c-o-r-r-e-c-t-i-o-n-teva-uk-ltd-9221/feed/</wfw:commentRss>
		</item>
	</channel>
</rss>

